Diphtheria
📧 Sign up to get email alerts when something new happens for Diphtheria.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination. [Phase 4]
A Phase 4 study evaluated the immunogenicity and safety (reactogenicity) of Boostrix administered 10 years after a prior booster, in individ…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Safety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in Children [Phase 3]
Phase 3 safety study results completed for combination vaccines Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY in child…
-
CLINICAL_TRIALS trial_result · 2017-03-16Clinical Trial Update: US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease [Phase 4]
Phase 4 trial update on US-licensed combined tetanus, diphtheria, and meningococcal vaccines; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants [Phase 3]
Phase 3 clinical trial update assessing immune memory and reactogenicity of the DTPw-HBV/Hib pentavalent vaccine in infants, including respo…
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Study to Assess Safety & Immunogenicity of GSK Biologicals' DTPa/Hib Vaccine vs Separate Administration of DTPa and Hib. [Phase 3]
Phase 3 trial evaluating safety and immunogenicity of GSK's DTPa/Hib vaccine compared with separate DTPa and Hib administration; the study i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: Safety of DTPa-IPV/Hib & DTPa-HBV-IPV/Hib, Followed by DTPa-IPV/Hib Vaccine in Infants Who Received Hepatitis B Vaccine [Phase 3]
A Phase 3 study evaluated the safety of two combination vaccines (DTPa-IPV/Hib and DTPa-HBV-IPV/Hib) in infants who had received hepatitis B…
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: Assess the Safety & Reactogenicity of DTPa-IPV/Hib Vaccine Administered at 3, 4, 5 & 18 Mths of Age, in Healthy Infants [Phase 4]
Phase 4 trial updating safety and reactogenicity of DTPa-IPV/Hib vaccine administered at 3, 4, 5 and 18 months in healthy infants; completed…
-
CLINICAL_TRIALS trial_result · 2017-01-04Clinical Trial Update: Post Marketing Surveillance for ADACEL™ in South Korea [Phase 4]
Phase 4 post-marketing surveillance study for ADACEL™ in South Korea evaluating diphtheria, tetanus, and pertussis in real-world use; study …
-
CLINICAL_TRIALS trial_result · 2017-01-04Clinical Trial Update: Regulatory Post-Marketing Surveillance Study for TETRAXIM™ [Phase 4]
Phase 4 post-marketing surveillance study for TETRAXIM. The trial completed and results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2016-12-29Clinical Trial Update: Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™ [Phase 4]
Phase 4 study assessing antibody persistence in children previously vaccinated with Infanrix Hexa or Infanrix-IPV/Hib; completed with result…
-
CLINICAL_TRIALS trial_result · 2016-12-12Clinical Trial Update: Safety of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Healthy Vietnamese Children [Phase 3]
Phase 3 trial update assessing safety of a booster dose of Boostrix vaccine in healthy Vietnamese children; results posted in 2016. Conditio…
-
CLINICAL_TRIALS trial_result · 2016-11-30Clinical Trial Update: Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants [Phase 4]
Phase 4 trial update on immunogenicity and safety of Infanrix Hexa in infants, with results posted after completion.
-
CLINICAL_TRIALS trial_result · 2016-11-21Clinical Trial Update: Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents [Phase 3]
Phase 3 study of BK1301 DTaP vaccine booster in adolescents completed; results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-11-04Clinical Trial Update: Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4 Months of Age [Phase 2]
Phase 2 trial update evaluating the immunogenicity and safety of a pentavalent DTPa-HBV-IPV/Hib vaccine given at 2, 3, and 4 months of age.
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Study to Assess Safety & Immunogenicity of GSK Biologicals' Boostrix (dTpa) Vaccine vs. Chinese DT Vaccine [Phase 3]
A Phase 3 trial comparing GSK Boostrix (dTpa) with a Chinese diphtheria-tetanus vaccine to assess safety and immunogenicity.
-
CLINICAL_TRIALS trial_result · 2016-10-27Clinical Trial Update: Study to Assess the Safety & Reactogenicity of GSK Biologicals' dTpa Vaccine (Boostrix) When Given at 6-8 Years of Age. [Phase 3]
A Phase 3 trial assessing the safety and reactogenicity of GSK's dTpa vaccine Boostrix when given to children aged 6-8 years; the study has …
-
CLINICAL_TRIALS trial_result · 2016-10-12Clinical Trial Update: Study to Assess the Safety & Reactogenicity of GSK Biologicals' DTPa/Hib Vaccine When Given at 3, 4 and 5 Months of Age [Phase 3]
A Phase 3 study assessing the safety and reactogenicity of GlaxoSmithKline's DTPa/Hib vaccine administered at 3, 4, and 5 months of age has …
-
CLINICAL_TRIALS trial_result · 2016-10-12Clinical Trial Update: Compare Immunogenicity & Safety of 2 Formulations of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine Given in Healthy Infants [Phase 3]
GlaxoSmithKline completed a Phase 3 trial comparing immunogenicity and safety of two formulations of the DTPa-HBV-IPV/Hib vaccine in healthy…
-
CLINICAL_TRIALS trial_result · 2016-10-07Clinical Trial Update: Lot-to-lot Consistency of Tritanrix™-HepB/Hib-MenAC & Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ in Infants [Phase 3]
The document reports Phase 3 results evaluating lot-to-lot consistency of Tritanrix-HepB/Hib-MenAC and its non-inferiority compared with Tri…
-
CLINICAL_TRIALS trial_result · 2016-10-07Clinical Trial Update: Immuno & Safety Study With 2 Formulations of DTPw-HBV/HIB When Given at Birth With Hepatitis B at 2, 4 and 6 Mths.Age. [Phase 3]
A Phase 3 immunization and safety study comparing two formulations of DTPw-HBV/HIB given at birth with Hepatitis B at 2, 4, and 6 months was…
-
CLINICAL_TRIALS trial_result · 2016-09-28Clinical Trial Update: Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination Schedules [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of GlaxoSmithKline's pentavalent DTPa-HBV-IPV/Hib vaccine in Indian infants across two va…
-
CLINICAL_TRIALS trial_result · 2016-09-28Clinical Trial Update: Assess Immunogenicity, Reactogenicity, Safety of a Booster of GSK Biologicals DTPw-HBV/Hib Kft Compared to DTPw-HBV/Hib [Phase 3]
Phase 3 booster study evaluating immunogenicity, reactogenicity, and safety of GSK's DTPw-HBV/Hib vaccine booster compared with the standard…
-
CLINICAL_TRIALS trial_result · 2016-09-23Clinical Trial Update: Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488 [Phase 2]
Phase 2 clinical trial update evaluating a booster dose of GlaxoSmithKline's 10-valent pneumococcal conjugate vaccine and a single dose of t…
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: Assess the Immune Response Following Primary Vaccination With GSK Biologicals' Tritanrix™-HepB/Hib-MenAC vs Tritanrix™-HepB/Hiberix™ Given at 6,10 & 14 Wks of Age to Infants Who Received Hepatitis B Vaccine at Birth [Phase 3]
This Phase 3 trial evaluated and compared the immune responses to two DTP-containing vaccines (Tritanrix-HepB/Hib-MenAC vs Tritanrix-HepB/Hi…
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: Immunogenicity & Safety Study of a Vaccine Against Meningitis in Infants (2,4,6 Months) After a Hepatitis B Birth Dose. [Phase 3]
A Phase 3 immunogenicity and safety study of an infant meningitis vaccine given after a hepatitis B birth dose completed; the trial evaluate…